FRONTOTEMPORAL DEMENTIA
Clinical trials for FRONTOTEMPORAL DEMENTIA explained in plain language.
Never miss a new study
Get alerted when new FRONTOTEMPORAL DEMENTIA trials appear
Sign up with your email to follow new studies for FRONTOTEMPORAL DEMENTIA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New drug trial aims to slow frontotemporal dementia
Disease control OngoingThis study tests a new drug called DNL593 for frontotemporal dementia, a brain disease that affects behavior and language. First, healthy volunteers get a single dose to check safety. Then, people with the disease receive multiple doses over 25 weeks to see if it helps control th…
Matched conditions: FRONTOTEMPORAL DEMENTIA
Phase: PHASE1, PHASE2 • Sponsor: Denali Therapeutics Inc. • Aim: Disease control
Last updated Apr 30, 2026 15:51 UTC
-
Rhythm and bonding: music therapy shows promise for dementia patients and caregivers
Symptom relief OngoingThis study explores whether rhythmic music activities can improve social attention and feelings of closeness between people with frontotemporal or Alzheimer's dementia and their caregivers. About 80 patient-caregiver pairs will participate. The goal is to see if making music toge…
Matched conditions: FRONTOTEMPORAL DEMENTIA
Phase: NA • Sponsor: University of California, San Francisco • Aim: Symptom relief
Last updated Apr 30, 2026 15:51 UTC
-
Can a head device help brain disease? researchers ask patients
Knowledge-focused ENROLLING_BY_INVITATIONThis study asks 1,000 people with neurological diseases like Alzheimer's or Parkinson's, and their caregivers, to share their experiences using a head device called MemorEM. The goal is to learn how to improve the device's design and make it easier to use in future studies. It is…
Matched conditions: FRONTOTEMPORAL DEMENTIA
Phase: NA • Sponsor: eQ8Health Corporation d/b/a CareONE Concierge • Aim: Knowledge-focused
Last updated May 01, 2026 15:57 UTC
-
Wearable sensors could transform how we track rare brain diseases
Knowledge-focused OngoingThis study is testing whether a wearable pendant sensor can reliably track movement symptoms in people with Progressive Supranuclear Palsy (PSP) and related disorders. About 60 participants will wear the sensor for 12 months while researchers check how well they stick with the de…
Matched conditions: FRONTOTEMPORAL DEMENTIA
Sponsor: Massachusetts General Hospital • Aim: Knowledge-focused
Last updated Apr 30, 2026 15:51 UTC